Prakash Bhuyan MD PhD

Senior Vice President, Clinical Development

3900 Woodland AveUniversity And Woodland AvenuesPhiladelphia, PA 19104

Dr. Bhuyan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhuyan's full profile Already have an account?

Education & Training

University of Pennsylvania Health SystemFellowship, Infectious Disease, 2001 - 2003
Emory University School of MedicineResidency, Internal Medicine, 1998 - 2001
University of Texas Southwestern Medical SchoolClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 2001 - 2026
GA State Medical License 1999 - 2001

Clinical Trials

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
COMPLETED
PHASE2
Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)
COMPLETED
PHASE3
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) Start of enrollment: 2006 Oct 06
COMPLETED
PHASE3

Publications & Presentations

PubMed

HPLC-MS/MS-based quantification of human monoclonal antibodies targeting SARS-CoV-2 in the presence of endogenous SARS-CoV-2 antibodies in human serum.
Alexander Schäfer, Peter Sagelsdorff, Björn Hock, Prakash Bhuyan, Norman Moullan
Analytical and Bioanalytical Chemistry. 2024-08-01
4 citations
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 M...
Norman Moullan, Josephat Asiago, Kathryn Stecco, Salah Hadi, Moetaz Albizem
Infectious Diseases and Therapy. 2024-01-01
7 citations
Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008-2018: The EACH-WOMAN Proj...
Katherine C Hughes, Timothy A Herring, Jennifer N Song, Robert V Gately, Lindsey M Przybyl
Journal of Lower Genital Tract Disease. 2023-04-01

Press Mentions

INOVIO to Present at Upcoming Investor Conferences in MarchMarch 2nd, 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) Q1 2020 Earnings Call TranscriptMay 11th, 2020
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-Associated Vulvar DysplasiaMarch 30th, 2020